FMC Service Andalucía-Córdoba, Avda. Conde de Vallellano 19, Córdoba, Spain.
Nefrologia. 2011;31(6):664-9. doi: 10.3265/Nefrologia.pre2011.Oct.11001.
The different clinical guidelines backed by the Spanish Society of Nephrology (SEN) attempt to homogenise the monitoring of renal patients. However, this effort to homogenise treatment has been obstructed in the case of renal replacement therapy patients on haemodialysis due to, among other reasons, the existence of several different dialysis providers, with private centres located in many cities, each with their own reference hospitals and different criteria for treatment based on the existing outsourcing services agreements with the public health service, which also differ between regions. A good relationship between a private dialysis centre and its reference hospital would lead to equal treatment for all dialysis patients, at least at that particular town. The SEN, through the efforts of the Grupo de Trabajo de Hemodiálisis Extrahospitalaria (Outpatient Haemodialysis Group), has prioritised a close relationship and good communication between reference hospitals and dialysis centres in order to guarantee proper continuity of the health care given to these patients.
Conditions for referring patients from one centre to another. A patient that starts a haemodialysis programme should be referred from a reference hospital with a definitive vascular access for optimising treatment, with a full report updated within 24-48 hours before the transferral, including essential information for providing proper nephrological treatment: primary pathology, recent viral serology (including hepatitis B and C virus [HBV and HCV] and human immunodeficiency virus [HIV]), parameters for anaemia and calcium-phosphorus metabolism, and ions, date of the first session of dialysis, and the number and dates of blood transfusions received. Furthermore, patients referred from the dialysis centre to the hospital, whether for programmed visits or emergency hospitalisation, should be accompanied by an updated report indicating the primary diagnoses, recent events, viral serology and laboratory analyses, updated haemodialysis and treatment regimens used, and the reason for transferral to the hospital. A single, digital clinical history that is accessible by both institutions would facilitate this situation, although this option is not completely available to all centres and hospitals. There are also legal issues to resolve in this aspect. Continued care for dialysis patients. Good communication between dialysis centres and hospitals is fundamental for achieving a proper level of care for dialysis patients, and not only with the nephrology department. The interconsultations of dialysis patients at each private centre, as well as the requests for diagnostic tests, should be able to be requested by the centre directly. The results and reports from these interconsultations should also be sent to the centre. It would also be best if the reference hospitals and their private dialysis centres shared common treatment protocols. These protocols should include basic aspects of the treatment of renal patients (anaemia, mineral metabolism, vascular accesses including catheter infections, etc., and laboratory tests), transplant protocols, complementary tests, and other components specific to each area. Not only would this generalise and unify the approach taken with dialysis patients regardless of where they are treated, it would also facilitate access to data on all patients regarding clinical trials and research studies. Access to medication. Dialysis patients require medications that are only given in the hospital setting, which is normally provided by the reference hospital, as per the agreement between institutions. It would also be recommendable that any other medications not included in the agreement (antibiotics, urokinase, nutritional supplements, etc.) be dispensed in a similar manner. Access to kidney transplant. The management of the transplant waiting list, once a patient starts renal replacement therapy, should be controlled from the dialysis centre, as in any other procedure. As such, the nephrologists from each centre should be familiar with the existing protocols and new developments in this context, and should participate in meetings with nephrology and urology departments in each hospital. The transplant protocol at each town/region should be followed for all patients, whether dialysis is undergone in a hospital or private centre. Characteristics of the work at dialysis centres. The doctor attending patients at each dialysis centre must be a specialist in nephrology. This complicated issue must be a requirement for agreements within the regional health system in order to guarantee a proper and equitable treatment of patients that receive dialysis in private centres. Only in the case of an absence of a nephrologist should a general practitioner be used, and this doctor must have adequate training in haemodialysis. This training should also be standardised. Over 75% of nephrologists that work at these centres are alone during the workday, and 40% never see another colleague during the whole shift. The administrators of these centres should seek out protocols that provide professional contact, both with the hospital staff and nephrologists from other centres, which would facilitate an exchange of ideas. Training. The nephrologists at each centre have the right and the obligation to perform research and to continuously expand their training, so as to develop and improve health care provision. Since the majority of patients in haemodialysis programmes are treated in outpatient centres that depend on reference hospitals, we might suggest a minimal rotation of nephrology residents in private outpatient dialysis centres, once accreditation has been given for providing this training.
西班牙肾脏病学会(SEN)的不同临床指南试图使肾患者的监测同质化。然而,由于存在多个透析提供者,其中包括许多城市中的私人中心,以及基于与公共卫生服务的外包服务协议的不同治疗标准,这种同质化治疗的努力在接受血液透析的肾替代治疗患者中受阻,这些协议在不同地区也有所不同。私人透析中心与其参考医院之间的良好关系将导致所有透析患者得到平等对待,至少在特定城镇如此。SEN 通过外门诊血液透析组(Outpatient Haemodialysis Group)的努力,优先考虑参考医院和透析中心之间的密切关系和良好沟通,以确保这些患者的医疗保健得到适当的连续性。
转诊条件。开始血液透析计划的患者应从具有优化治疗用永久性血管通路的参考医院转诊,在转诊前 24-48 小时内更新完整报告,包括提供适当肾科治疗所需的基本信息:主要病理学、最近的病毒血清学(包括乙型肝炎和丙型肝炎病毒[HBV 和 HCV]和人类免疫缺陷病毒[HIV])、贫血和钙磷代谢以及离子参数、透析的第一次治疗日期以及接受的输血次数和日期。此外,从透析中心转诊到医院的患者,无论是计划就诊还是紧急住院,都应附有一份最新报告,说明主要诊断、最近的事件、病毒血清学和实验室分析、更新的血液透析和治疗方案以及转诊至医院的原因。如果所有中心和医院都能使用单一、可访问的数字临床病史,那么这种情况将会得到改善,尽管并非所有中心都完全可以使用此选项。在这方面还存在法律问题需要解决。透析患者的持续护理。透析中心和医院之间的良好沟通对于实现透析患者的适当护理水平至关重要,而不仅仅是与肾病科。每个私人中心的透析患者的会诊以及诊断测试的请求,都应该能够由中心直接提出。会诊的结果和报告也应该发送给中心。最好的情况是参考医院及其私人透析中心共享共同的治疗方案。这些方案应包括肾患者治疗的基本方面(贫血、矿物质代谢、包括导管感染在内的血管通路等,以及实验室检查)、移植方案、补充检查以及每个地区的其他特定内容。这不仅会使无论在何处接受治疗的透析患者的治疗方法变得普遍和统一,还将方便访问所有患者关于临床试验和研究的相关数据。药物获取。透析患者需要仅在医院环境中提供的药物,通常由参考医院根据机构之间的协议提供。还建议以类似的方式配给不在协议范围内的任何其他药物(抗生素、尿激酶、营养补充剂等)。肾移植的获取。一旦患者开始肾替代治疗,就应该从透析中心控制移植等待名单的管理,就像任何其他程序一样。因此,每个中心的肾病医生都应该熟悉现有的协议和这方面的新发展,并应参加每个医院的肾病和泌尿科部门的会议。无论透析是在医院还是私人中心进行,都应遵循每个城镇/地区的移植方案。透析中心工作的特点。每个透析中心的患者就诊医生必须是肾脏病专家。为了保证在私人中心接受透析的患者得到适当和平等的治疗,这一复杂的问题必须是区域卫生系统协议的要求。只有在没有肾病医生的情况下,才可以使用全科医生,并且该医生必须具备血液透析方面的充分培训。这种培训也应该标准化。在这些中心工作的 75%以上的肾病医生在工作日期间独自工作,40%的医生在整个轮班期间从未见过另一位同事。这些中心的管理员应该寻求提供专业联系的协议,包括与医院工作人员和其他中心的肾病医生的联系,这将促进思想的交流。培训。每个中心的肾病医生都有权并有义务进行研究并不断扩大培训,以发展和改善医疗保健服务。由于大多数血液透析计划的患者都在依赖参考医院的门诊中心接受治疗,我们可以建议在私人门诊透析中心为提供这种培训提供认证后,轮换一些肾病住院医生。